Atlas Trials

Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites

Clinical trial NCT01349335 · COMPLETED

Trial details

NCT number
NCT01349335
Sponsor
Otsuka Beijing Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
AscitesHepatic Cirrhosis
Start date
2009-04-01
Primary completion
2010-01-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.